Invention Grant
- Patent Title: Crystalline forms of a MAGL inhibitor
-
Application No.: US18051654Application Date: 2022-11-01
-
Publication No.: US12152029B2Publication Date: 2024-11-26
- Inventor: Thomas Vetter , Martin Juhl , Heidi Lopez De Diego , Cheryl A. Grice , John J. M. Wiener , Daniel J. Buzard , Amy Allan , Susana Del Rio Gancedo , Samuel George Andrew , Antonio Cincotti , Adam Ross Patterson , Richard James Edwards
- Applicant: H. Lundbeck A/S
- Applicant Address: DK Valby
- Assignee: H. Lundbeck A/S
- Current Assignee: H. Lundbeck A/S
- Current Assignee Address: DK Valby
- Agency: WILSON SONSINI GOODRICH & ROSATI
- Main IPC: C07D471/10
- IPC: C07D471/10
Abstract:
Described herein are new crystalline forms of the MAGL inhibitor 1-(1-(2-(pyrrolidin-1-yl)-4-(trifluoromethyl)benzyl)-1,8-diazaspiro[4.5]decane-8-carbonyl)-1H-pyrazole-3-carboxylic acid, or a pharmaceutically acceptable salt thereof.
Public/Granted literature
- US20230265095A1 CRYSTALLINE FORMS OF A MAGL INHIBITOR Public/Granted day:2023-08-24
Information query
